Neuroinflammation
17
4
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
5.9%
1 terminated out of 17 trials
85.7%
-0.8% vs benchmark
12%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
The Effect of Celecoxib on Neuroinflammation in MDD
The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals
Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery
Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery
Tinnitus and Treatment With umPEA-LUT
Neuroinflammatory Biomarkers After General Anesthesia: A Comparison Study
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT)
Studying the Neurobiological Mechanisms of Non-specific Chronic Low Back Pain and Chronic Insomnia: a Four-group Cross-sectional Study
Translocator Protein PET/CT in Various TSPO-Related Disease
Imaging - Clinical Evaluation of Altered Nervous System Drainage
Neuroinflammation/Oxidative Stress/Cardiac Surgery
The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.
The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment
Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer